Clinical Trial: Prediction of Left Ventricular Adverse Remodeling and Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction Though Plasma Multiomics Analysis.

U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06885619) titled 'Prediction of Left Ventricular Adverse Remodeling and Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction Though Plasma Multiomics Analysis.' on March 14.

Brief Summary: To identify plasma multi-omics biomarkers that predict left ventricular adverse remodeling (LVAR) and major adverse cardiovascular events (MACE) in patients with acute myocardial infarction, and to investigate the molecular pathways linked to LVAR and MACE.

Study Start Date: Jan. 01

Study Type: OBSERVATIONAL

Condition: Acute Myocardial Infarction (AMI) Left Ventricular Remodeling Major Adverse Cardiovascular Event Plasma Multi-Omics...